Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The Acute Respiratory Distress Syndrome (ARDS) Market Expected To Expand Between 2025 And 2029?
The acute respiratory distress syndrome (ards) market size has demonstrated significant expansion in recent years. It is anticipated to grow from $1.29 billion in 2024 to $1.41 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.4%. This historical growth can be attributed to advancements in critical care medicine, an aging population, progress in pulmonary rehabilitation, and the implementation of multidisciplinary care teams.
The market for acute respiratory distress syndrome (ARDS) is projected to experience swift expansion over the coming years. This market is anticipated to reach $2.15 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.1%. Several factors are expected to drive this growth during the forecast period, including advancements in global healthcare preparedness, the progress in vaccine development and infectious disease management, the expansion of telemedicine and remote monitoring, and the adoption of patient-centered care models. Key trends predicted for the forecast period encompass innovations like artificial lung devices, the implementation of personalized ventilation strategies, the widespread use of lung protective ventilation, and the development of targeted drug therapies for ARDS subtypes.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13005&type=smp
Which Drivers Are Shaping The Acute Respiratory Distress Syndrome (ARDS) Industry’s Market Share?
The increasing incidence of pneumonia is projected to drive the expansion of the acute respiratory distress syndrome (ARDS) market in the future. Pneumonia is an infection that impacts one or both lungs, resulting in the filling of the air sacs, or alveoli, with fluid or pus. This condition induces an inflammatory response within the lungs, which heightens blood vessel permeability and causes fluid to leak into the alveoli. Such fluid accumulation impedes the normal exchange of oxygen and carbon dioxide, leading to respiratory distress. For instance, in November 2023, reports from the Centre for Tropical Medicine and Global Health, a leading UK-based healthcare research organization, showed a significant surge in pneumonia cases in Kenya, reaching 793,864 in 2022-2023, an increase from 477,186 cases in 2020-2021. Thus, the escalating prevalence of pneumonia is a key driver for the growth of the acute respiratory distress syndrome (ARDS) market.
What Are The Major Segment Categories Driving The Acute Respiratory Distress Syndrome (ARDS) Market Growth?
The acute respiratory distress syndrome (ards)market covered in this report is segmented –
1) By Type: Diagnosis; Treatment
2) By Cause: COVID-19 Disease 2019 (COVID-19); Sepsis; Inhalation Of Harmful Substances; Severe Pneumonia; Other Causes
3) By Severity: Mild; Moderate; Severe
4) By End User: Hospitals; Clinics; Ambulatory Service Centers; Other End Users
Subsegments:
1) By Diagnosis: Imaging Tests; Blood Tests; Lung Function Tests; Other Diagnostic Methods
2) By Treatment: Mechanical Ventilation; Medications; Extracorporeal Membrane Oxygenation (ECMO); Supportive Care; Other Treatment Options
Which Key Trends Are Expected To Influence The Acute Respiratory Distress Syndrome (ARDS) Market In The Coming Years?
Major companies operating in the acute respiratory distress syndrome (ARDS) market are prioritizing the creation of innovative drugs and supplements, including Aviptadil, HSP90 inhibitors, and others, to sustain their market presence. Aviptadil is a synthesized vasoactive intestinal peptide (VIP) that specifically attaches to receptors found on lung alveolar type II cells. For instance, in November 2022, Zuventus Healthcare Ltd., an India-based pharmaceutical manufacturing company, launched Aviptadil for treating acute respiratory distress syndrome. As a vasoactive intestinal peptide supplement, Aviptadil enhances respiration and reduces mortality in ARDS patients. This effect is achieved through Aviptadil’s ability to protect and regenerate Type-2 Pneumocytes, restore Type-1 Pneumocytes, boost surfactant synthesis, and suppress IL-6 (interleukin 6) and tumor necrosis factor (TNF)-alpha.
Who Are The Core Companies Influencing The Acute Respiratory Distress Syndrome (ARDS) Market Landscape?
Major companies operating in the acute respiratory distress syndrome (ards) market are Johnson & Johnson Services Inc., Novartis AG, GlaxoSmithKline PLC, Medtronic PLC, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Fresenius SE & Co. KGaA, Koninklijke Philips N.V., Baxter International Inc., Teva Pharmaceutical Industries Ltd., CSL Behring, Terumo Corporation, ResMed Inc., Smiths Medical Inc., Dräger Safety AG & Co. KGaA., Getinge AB, Mallinckrodt PLC, Masimo Corporation, United Therapeutics Corporation, Fisher & Paykel Healthcare Corporation Limited, Hamilton Medical AG, Zuventus Healthcare Ltd., Windtree Therapeutics Inc., Faron Pharmaceuticals Oy, AcelRx Pharmaceuticals Inc.
Download The Full Report For Exclusive Market Findings:
How Does The Acute Respiratory Distress Syndrome (ARDS) Market Perform Across Key Geographic Regions?
North America was the largest region in the acute respiratory distress syndrome (ARDS) market in 2024. The regions covered in acute respiratory distress syndrome (ARDS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Acute Respiratory Distress Syndrome (ARDS) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13005&type=smp
Browse Through More Reports Similar to the Global Acute Respiratory Distress Syndrome (ARDS) Market 2025, By The Business Research Company
Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2025
Respiratory Disposables Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/respiratory-disposables-global-market-report
Respiratory Devices And Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model